NDUFAF2, NADH:ubiquinone oxidoreductase complex assembly factor 2, 91942
N. diseases: 89; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.160 | 5 | 60944972 | stop gained | C/A | snv | 7.6E-05 | 4.9E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases | 0.710 | 1.000 | 2 | 2004 | 2010 | ||||||
|
0.882 | 0.120 | 5 | 61073136 | stop gained | C/T | snv | 4.0E-05 | 3.5E-05 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 9 | 2000 | 2016 | ||||||
|
0.882 | 0.120 | 5 | 61073136 | stop gained | C/T | snv | 4.0E-05 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 1.000 | 9 | 2000 | 2016 | ||||||
|
0.882 | 0.120 | 5 | 61073136 | stop gained | C/T | snv | 4.0E-05 | 3.5E-05 |
|
Nutritional and Metabolic Diseases | 0.700 | 1.000 | 2 | 2005 | 2016 | ||||||
|
5 | 61090826 | intron variant | C/T | snv | 0.41 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
5 | 61088344 | intron variant | T/C | snv | 0.76 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 0.120 | 5 | 61073136 | stop gained | C/T | snv | 4.0E-05 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2005 | 2005 | ||||||
|
1.000 | 0.040 | 5 | 61063883 | intron variant | A/G | snv | 0.41 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 5 | 61063883 | intron variant | A/G | snv | 0.41 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 5 | 60945264 | stop gained | G/A | snv |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
1.000 | 0.040 | 5 | 60964716 | intron variant | C/G;T | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.040 | 5 | 61144544 | intron variant | T/C | snv | 4.9E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 5 | 61144544 | intron variant | T/C | snv | 4.9E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 5 | 60978096 | intron variant | C/A;T | snv |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
5 | 61002533 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
5 | 61049924 | intron variant | C/T | snv | 0.81 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
5 | 60947457 | intron variant | C/A | snv | 2.6E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
5 | 61056756 | intron variant | C/T | snv | 0.41 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.120 | 5 | 61098995 | stop gained | G/A | snv | 2.0E-05 | 1.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.882 | 0.120 | 5 | 61073136 | stop gained | C/T | snv | 4.0E-05 | 3.5E-05 |
|
0.700 | 0 | ||||||||||
|
1.000 | 0.160 | 5 | 60944930 | splice donor variant | A/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 5 | 60945256 | start lost | A/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 5 | 60945358 | frameshift variant | A/- | del |
|
0.700 | 0 | |||||||||||||
|
1.000 | 5 | 60945369 | stop gained | C/G | snv | 5.6E-05 | 2.8E-05 |
|
0.700 | 0 | |||||||||||
|
0.851 | 0.120 | 5 | 60943616 | intron variant | G/A | snv | 0.63 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2015 | 2018 |